Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors predictive of response to hormone therapy in breast cancer.

Tumori - 1 Jan 2000

Rastelli Francesca, Crispino Sergio

Abstract excerpt

AIMS AND BACKGROUND: Approximately half of metastatic breast cancers expressing estrogen and/or progesterone receptors responds to endocrine therapy, and postoperative adjuvant endocrine therapy provides about a 50% reduction in the development of recurrent disease. A number of publications have focused on the correlation of biomarkers, in particular estrogen and progesterone receptors and HER-2/neu status as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Aromatase Inhibitors
Share to Nitriles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Receptor, ErbB-2

Share to Receptors, Progesterone

Share to Selective Estrogen Receptor Modulators

Share to Tamoxifen

Share to Triazoles

Source

Identifiers

PMID: 18705406
DOI: 10.1177/030089160809400314

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors predictive of response to hormone therapy in breast cancer.PMID 18705406Read ↗

Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer.Semantic proximity Read ↗

Use of molecular markers for predicting therapy response in cancer patients.Semantic proximity Read ↗

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An updateSemantic proximity Read ↗

Prognostic markers in triple-negative breast cancer.Semantic proximity Read ↗

Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer.Semantic proximity Read ↗

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read ↗

[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications].Semantic proximity Read ↗

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersSemantic proximity Read ↗

Molecular characterization of the residual disease after neoadjuvant endocrine therapy in ER+/HER2- breast cancer uncovers biomarkers of tumour responseSemantic proximity Read ↗

Predictive factors for response to neoadjuvant therapy in breast cancer.Semantic proximity Read ↗

Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE.Semantic proximity Read ↗

Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to LetrozoleSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.